Report Wire

Tag: rollout

  • OnePlus 8T and Nord get new updates

    OnePlus is presently pushing new updates to 2 of its latest smartphones, the 8T and the Nord. The 8T is receiving the November safety patch, whereas the lower-end Nord goes to have the December safety stage, which is a bizarre distinction, however hey – not less than you are getting new safety fixes regardless of which of those telephones you’ve.

    The changelog for the replace going out to the OnePlus 8T additionally mentions an optimized expertise for gesture navigation, an elevated success charge for fingerprint unlocking, a newly added keyboard peak adjustment, higher picture high quality for Nightscape pictures, improved total stability of communications, in addition to the addition of the OnePlus Store app for Indian items.

    The replace additionally fixes a problem that prevented images from displaying within the Gallery for some customers, and a problem which made Wi-Fi connection fail in a selected state of affairs. The new software program is rolling out to a small subset of OnePlus 8T items first, adopted by a wider distribution in just a few days if no show-stopping bugs are discovered. You’re getting the replace as OxygenOS 11.0.6.7 in India and North America, and OxygenOS 11.0.6.8 in Europe.

    Moving on to the Nord, the identical caveats in regards to the rollout timing apply. This handset is receiving OxygenOS 10.5.10 internationally, and apart from the nonetheless present safety fixes you additionally get a brand new GMS package deal, common bug fixes and improved stability, in addition to the OnePlus Store preinstalled in India.

  • 22,273 new COVID-19 cases reported in India, daily deaths below 300 after over six months

    With 22,272 new COVID-19 cases recorded in the last 24 hours, India’s infections tally has reached 1,01,69,118, informed the Union Ministry of Health and Family Welfare on Saturday.

    The country witnessed 251 new COVID-19 deaths during the same period, taking the cumulative toll to 1,47,343. At present, there are 2,81,667 active cases, while the overall recoveries have reached 97,40,108 as 22,274 people were discharged in the last 24 hours.

    As many as 16,71,59,289 samples were tested up to December 25, including 8,53,527 samples tested on Friday, according to the Indian Council of Medical Research (ICMR).

    Meanwhile, Bharat Biotech Chairman and Managing Director Dr Krishna Ella and Joint Managing Director Suchitra Ella had called on Vice President M Venkaiah Naidu in Hyderabad to discuss the status of the indigenous vaccine against COVID-19 and the plans to make it available in India and the rest of the world.

    ‘Covaxin’ is being developed by Bharat Biotech in collaboration with ICMR – National Institute of Virology (NIV).

    On Wednesday, the Ministry of Electronics and Information Technology had announced the ‘Grand Challenge for Strengthening ‘CoWIN’ the COVID Vaccine Intelligence Network’, a digitalised platform for the effective national rollout and scaling up of the COVID Vaccine Distribution System.

    As per a statement, winners of the challenge will get rewards totaling Rs 3.85 crores. Registration will be open for participants till January 15, 2021.

  • Trump Promises ‘free Vaccines’ After Pfizer’s COVID-19 Vaccine Earns FDA Nod

    The US on Friday has given a green light to the nation’s first COVID-19 vaccine. The development came after the US Food and Drug Administration authorized an emergency rollout of a vaccine from Pfizer Inc. and its German partner BioNTech. US President Donald Trump has reacted to the development and assured free vaccine for all Americans.  Taking to Twitter, Trump announced that the FDA’s decision to authorize emergency use of Pfizer’s Covid vaccine. Terming the decision as a ‘medical miracle’ Trump has thanked all the scientists, doctors and workers for the vaccine. In addition, Trump has also stated that his administration had disbursed over two hundred million dollars to Pfizer for the development of over a hundred million doses of the vaccine. Trump further assured that the vaccine will be free for all Americans. Following the nod from the FDA, the US government had also tied up with FedEx and UPS to ship the vaccine doses to every state in the country. Apart from this announcement, Trump has also remarked that the vaccine’s first dose will be administered within 24 hours. However, Trump has expressed that the senior citizens, healthcare workers and first responders will be the first ones to receive Pfizer’s Covid vaccine. 

  • WHO Urges People To Follow COVID-19 Safety Measures Even After Vaccine Rollout

    The World Health Organization, during a media briefing on December 4, urged people to follow the safety measures even after the vaccine is rolled out as it will not put an end to the deadly virus. WHO director-general Tedros Adhanom Ghebreyesus said that the progress in vaccines gives people a lift ‘and we can now start to see the light at the end of the tunnel’. He also said that the organization is worried about the growing perception of people about how the pandemic is over as this can turn out to be harmful.The COVID-19 pandemic which saw its first outbreak in a wet market in Wuhan, China last year has now spread all across the world. The virus, named COVID-19 by the World Health Organisation, has infected over 65 million people worldwide with the global death toll at 1,524,462. As per the John Hopkins coronavirus resource centre, the United States has reported a total of 14,772,535 positive virus cases and has a death toll of 285,550.The US currently has the highest number of reported cases in the world, making it the epicentre of the deadly virus.Recently, Pfizer Inc’s CEO Albert Bourla has said that the company is “not certain” if its COVID-19 vaccine candidate developed in collaboration with German drugmaker BioNTech SE prevented the transmission of the novel coronavirus. This comes just days after the UK became the world’s first country to give formal authorisation to Pfizer-BioNTech’s mRNA-based COVID-19 vaccine for mass rollout. Also, Bahrain on December 5 became the second nation in the world to grant an emergency-use authorisation for the coronavirus vaccine made by Pfizer. However, the country did not reveal information about the number of vaccines that it had purchased. Pfizer told the Associated Press that the details of its sales agreement with Bahrain, including the “timing of delivery and the volume of doses,” was confidential and declined to comment.

  • Apple to launch 2021 iPad Pro with 5G mmWave support: Know details

    Apple is reportedly planning to launch 5G-enabled high-end iPad Pro models next year with mmWave support. According to DigiTimes, Apple’s success in developing its own in-house mmWave (antenna in package) modules for next year’s iPhone lineup has increased the likelihood that next-generation models in Apple’s iPad range will also benefit.

    mmWave or millimetre-wave is a set of 5G frequencies that promise ultra-fast speeds at short distances, making it best suited for dense urban areas. iPhone 12 models in the US exclusively support mmWave, while next year’s iPhone series could see a wider rollout of the technology.

    Famed Apple analyst Ming-Chi Kuo in his latest investors’ note claimed that new mini-LED iPad Pros will begin production in the fourth quarter of 2020, so one can expect them to be launched sometime in the first half of 2021.

    It is believed that Apple is also getting ready to deliver six new mini-LED devices, out of which, we may also get a new 16-inch and a 14-inch MacBook Pro in the second half of 2021.

    Apple is reportedly investing around $330 million in the Taiwan-based company for a micro-LED factory that will manufacture displays for future iPhones, iPads, MacBooks, and other devices from Apple.